Clinical trials - Press Releases

Date	Title	Company
14-Dec-2020	Emapalumab submission in China for primary HLH	Orphan Biovitrum AB
14-Dec-2020	Novo Holdings Creates New Rare Bleeding Disorder Company, Hemab	Novo Holdings
14-Dec-2020	Trixeo Aerosphere approved in the EU for maintenance treatment of COPD	AstraZeneca
14-Dec-2020	Celltrion Healthcare receives EU CHMP positive opinion for biosimilar adalimumab, CT-P17	Celltrion Healthcare
14-Dec-2020	Grant awarded to Qlucore to aid clinical diagnostics of cancer	Qlucore
14-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
14-Dec-2020	The Sputnik V vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials	Russian Direct Investment Fund
10-Dec-2020	University spin-out fund makes half a million pound first investments	Northern Accelerator
10-Dec-2020	European study shows: Poor health literacy a major challenge to self-care[1] with opportunity for pharmacists to play a more prominent role	GSK / GSK Consumer Healthcare
10-Dec-2020	Almac Group Granted Phase I Award Under the ‘Sustainable Innovation Fund’ to Aid COVID-19 Recovery	Almac Group
10-Dec-2020	RDIF and RCIF participate in meeting of Intergovernmental Russian-Chinese Commission for Investment Cooperation	Russian Direct Investment Fund (RDIF)
10-Dec-2020	ALUNBRIG▼(brigatinib) now available on the NHS in England, Wales and Northern Ireland for adults with ALK-positive advanced non-small cell lung cancer who have not been previously treated with an ALK inhibitor	Takeda UK Ltd
10-Dec-2020	Stats show increase in mental health drugs prescribed during pandemic	NHS Business Services Authority’s (NHSBSA)
10-Dec-2020	PureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in Lymphedema	PureTech Health plc
10-Dec-2020	Atox Bio Announces FDA Acceptance to File the NDA for Reltecimod to Treat Suspected Organ Dysfunction or Failure in Patients with Necrotizing Soft Tissue Infection (“Flesh-Eating Disease”)	Atox Bio
10-Dec-2020	Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents	Moderna
10-Dec-2020	CPL UK Healthcare (RIG) win back to back framework awards across the NHS.	CPL UK Healthcare
09-Dec-2020	Orgenesis signs joint venture with Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies	Orgenesis Inc
09-Dec-2020	Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer	Evelo Biosciences, Inc
09-Dec-2020	RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer	Exact Sciences Corp